Skip to content Skip to footer

An audit was conducted in the Drug Quality Control and Bioequivalence Studies Department in accordance with international GLP/GCLP principles.

An audit was conducted in the Drug Quality Control and Bioequivalence Studies Department in accordance with international GLP/GCLP principles.

Bioanalytical testing of biological samples is ongoing in the Drug Quality Control and Bioequivalence Studies Department.

During the testing process, the appropriate analytical method was developed and validated, and an audit was conducted based on these activities.
The audit was conducted in accordance with GLP/GCLP (Good Laboratory Practice/Good Clinical Laboratory Practice) principles, during which the expert performed an assessment and verified the compliance of the studies with the applicable principles and quality management requirements.
The audit was conducted by Maria Zaitseva, a leading expert in the field of preclinical and clinical research, GLP systems expert, member of the British Association of specialists in scientific and clinical research quality, and Candidate of Medical Sciences.

Positive results were recorded during the audit, confirming that the conduct and outcomes of the studies are reliable and compliant with international requirements.